GNI GROUP LTD.
Contact Us
About Us
About Us TOP
Message
Business Model
Main Products
Management Policy
Company Overview
Board of Directors
Main Group Structure
Office
Corporate governance
R&D
R&D TOP
Pipeline
Discovery Research
Research publications
Investor Relations
Investor Relations TOP
IR News
Information
IR Materials
IR Calendar
IR Email Subscription
Electronic Public Notices
Sustainability/ESG
Sustainability/ESG TOP
Sustainability Initiatives
ESG Data
Contact Us
Site Map
Privacy Policy
Terms of Use
ソーシャルメディアポリシー
2015's Information
トップページ
Information
2015年
All
2025
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2015/12/08
57th Annual General Meeting of the American Society of Hematology Presentation of clinical trial results from China on tamibarotene as a treatment for acute promyelocytic leukemia
2015/07/06
Macquarie Securities report on GNI was posted on Bloomberg
2015/04/27
Initiation of Postmarketing Surveillance Studies of Etuary
2015/03/06
Notice of email server maintenance
2015/02/27
Announcement of the 14th Annual General Shareholder Meeting
2015/01/30
Notice of Completion of Investment inIriSys, LLC
2015/01/20
Notice of Investment in IriSys, LLC and Establishment of New U.S. Subsidiary